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Abstract 
Introduction:  Poor insight, or unawareness of some major aspect of mental illness, is a major 
barrier to wellness when it interferes with persons seeking out treatment or forming their own 
understanding of the challenges they face. One barrier to addressing impaired insight is the 
absence of a comprehensive model of how poor insight develops.  
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Areas covered:  To explore this issue we review how poor insight is the result of multiple 
phenomena which interfere with the construction of narrative accounts of psychiatric challenges, 
rather than a single social or biological cause.  
Expert Commentary:  We propose an integrative model of poor insight in schizophrenia which 
involves the interaction of symptoms, deficits in neurocognition, social cognition, metacognition, 
and stigma. Emerging treatments for poor insight including therapies which focus on the 
development of metacognition are discussed. 
Keywords: schizophrenia, insight, symptoms, neurocognition, social cognition, metacognition, 
stigma
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1. Introduction 
Many with schizophrenia spectrum disorders are unaware of key aspects of their 
condition [1, 2] and as a result are at risk for especially poorer outcomes [3, 4]. This 
unawareness, referred to as poor or impaired insight, has been divided generally into two forms. 
The first, clinical insight, is a multidimensional construct that includes at least three different 
domains: awareness of symptoms, need for treatment, and potential consequences of the disorder 
[1]. The second form of insight, cognitive insight, refers to awareness of alterations in reasoning 
processes [5]. Lack of cognitive insight in those with schizophrenia can, for example, involve 
being excessively certain about the accuracy of a belief or being less reflective about one’s own 
thoughts and feelings [6]. Impaired insight is linked to important outcome variables such as 
treatment non-adherence [7-9], higher rates of re-hospitalization [10], poorer social skills [11], 
reduced social relationships [12, 13], compromised work performance [14,15], and a longer 
duration of untreated psychosis [16, 17]. Impaired insight has also been linked to concurrent and 
prospective assessments of quality of life [18], poorer personal recovery [19], and poor global 
functioning [20, 21]. In line with this, other investigations have shown that individuals with 
higher levels of insight are better able to appraise their level of psychosocial functioning [22] and 
tend to have more self-efficacy when compared to individuals with poorer insight [23]. 
Importantly, impaired insight has not been found to be explainable merely by demographic 
factors [24].  
Impaired insight has been shown to persist even in individuals whose symptoms have 
remitted [25] and is found across different cultures [26, 18] and phases of illness [27-30].  In 
terms of responsiveness to intervention, individuals with impaired insight tend to have negative 
attitudes toward [31-34], and are less likely to adhere to [35], treatment. With medication, for 
instance, poor adherence is mediated by patients’ perceptions of medication necessity [36]. With 
regard to psychosocial interventions, impaired insight predicts poorer therapeutic alliance [37], 
even for manualized psychotherapy [38].  
To date, efforts to promote insight have been fraught with many complications. Efforts to 
engage individuals with schizophrenia and poor insight in treatment may indeed be experienced 
as intrusive or overwhelming to those individuals rather than as benevolent or helpful. Moreover, 
such efforts are potentially inconsistent with contemporary models of recovery from mental 
illness that argue that individuals facing psychiatric challenges need to feel empowered, hopeful, 
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and in charge of their own recovery [39]. It may be that direct attempts to help individuals accept 
that they suffer from a mental illness may have the iatrogenic effect of making those individuals 
feel incompetent and lead them to give up trying to make their own sense of their challenges, 
accepting that that can only be done by more powerful others.  
We suggest that the primary barrier to developing methods to address insight which are 
consistent with a recovery-oriented approach is a lack of a coherent multidimensional model of 
how poor insight develops and persists. To address this issue, the present review will examine 
recent literature on the correlates and consequences of impaired insight. Specifically, we will 
discuss processes that contribute to impaired insight and then examine innovative therapeutic 
approaches and future directions to improving insight in schizophrenia. Of note, while the 
literature had previously tended to debate whether poor insight is a reflection of biological vs. 
psychosocial forces (e.g. anosognosia versus denial as defense mechanism), we will avoid any 
such simplification and approach poor insight as a multi-determined phenomenon. Literature 
reviewed was found through a search of PubMed and SCOPUS including the search terms 
insight, awareness of illness, self-reflection, psychosis, and schizophrenia.  
 
2.  Poor Insight in Schizophrenia as a Disturbance in Reflectivity 
Considered as a whole it is important to establish that conceptually, impaired insight is 
not simply the failure to grasp a specific fact or agree with a certain label. It is not a lack of 
particular form of knowledge (e.g. about mental illness) or a global unawareness of the world as 
can be the case with dementia. Poor insight can persist in the midst of other intact forms of 
awareness. For instance, an individual with schizophrenia may deny that hearing voices is a 
symptom of his/her own mental illness and yet recognize that if someone else is hearing voices it 
is indeed part of their mental illness [40]. In addition, individuals with impaired insight may 
respond in an adaptive manner to other life demands or meaningfully appraise other aspects of 
their health [41].  
Poor insight is instead a failure to make adaptive meaning of psychiatric challenges [2]. 
Insight is a phenomenon involving not only the acceptance of the facts associated with one’s 
illness, but also the integration of a range of experiences into complex understanding of one’s 
psychiatric challenges. Individuals with poor insight have ultimately failed to some degree to 
construct an integrated account of the deeply complex events which marked the emergence and 
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possibly the persistence of mental illness in their lives. Poor insight refers to a state in which 
persons have not developed a consensually valid narrative of their psychiatric challenges which 
would allow for those events to be understood and responded to adaptively [42]. As an 
illustration, poor insight may describe a failure to see how the loss of a job and a romantic 
relationship, coupled with the emergence of intense fear, anxiety, and paranoid beliefs over a 
period of months may have signaled the appearance of a psychiatric condition.   
In this sense, poor insight is in part a failure of self-reflection or the capacity for 
reflectivity. Reflectivity in this sense refers to the process by which persons synthesize and 
comprehend ideas about themselves. We suggest that a key implication of this conceptualization 
is that an adequate model of impaired insight must include a description of the factors which 
account for disturbed reflectivity. To help develop such an account, in what follows we will 
consider different phenomenon observed in schizophrenia spectrum disorders that could limit 
persons’ abilities to construct narrative accounts of psychiatric challenges. Specifically, we will 
focus on the potential of different classes of symptoms, deficits in neurocognition, social 
cognition, metacognition, and social factors such as stigma to contribute to poor insight.  
 
3.  Psychiatric Symptoms 
 One potential set of factors that could disturb the potential for insight are the symptoms 
of schizophrenia itself. Positive symptoms such as hallucinations and delusions are often 
disturbing and novel experiences which could be difficult to reflect about and create an 
understanding of through either one’s own reflections or  conversations with others. Negative 
symptoms such as avolition, paucity of thought, and blunted affect similarly represent changes in 
mental states and could naturally be difficult to explain or think about. In support of these 
possibilities, poor insight has been linked with heightened positive [43] and negative [44] 
symptoms. However, it is important to note that these relationships have not been consistently 
found [45,46].  
One factor complicating the study of insight and symptoms is that it is unclear whether 
symptoms are a barrier to the development of insight or whether poor insight leads to treatment 
nonadherence which then can result in symptom exacerbation in both first episode and prolonged 
schizophrenia samples [47, 43, 2, 26, 18]. Mintz [48] performed a meta-analysis on over 40 
studies of insight and positive and negative symptom severity and found that while insight and 
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symptom severity were related, that relationship was only slight, with symptom severity 
accounting for 7% of the variance in insight. Both age of onset and acuity of disease state served 
as moderating variables. Similarly, Wang and colleagues [18] found that insight was related to 
baseline assessments of symptoms, but the relationship was no longer significant at 12-month 
follow up. In a 12-month longitudinal investigation, individuals whose insight did not improve 
over the course of the study were found to have particularly recalcitrant negative symptoms 
relative to those individuals with initially good or improved insight [49]. The authors suggest 
that impaired insight may contribute to the maintenance of negative symptoms rather than the 
other way around. By contrast, another recent study found that the association among insight and 
negative symptoms was no longer statistically significant once disorganization symptoms were 
accounted for [50].  
In terms of cognitive insight, one study examining potential moderators of the association 
among cognitive insight and positive symptoms suggested that poor insight is more likely to be 
associated with positive symptoms when individuals with these symptoms also have a naïve self-
concept [51]. Other work suggests that individuals with depressive symptoms have better 
cognitive insight that those without such symptoms [52]. In a study by Quee and colleagues [53], 
the relationship among insight and symptoms was found to be more complicated and likely 
moderated by phase of illness. Regression analyses revealed that insight accounted for 
significant variance in those individuals with multiple episodes of illness, but not in those with 
recent onset. 
One possible parsimonious explanation for these mixed findings is that symptoms may be 
a partial, albeit small, contributor to the development of insight. In other words, symptoms 
severity may sometimes affect insight for some persons in some conditions. As noted in Garcia, 
Guerro & Lysaker [51], for example, perhaps severe symptoms are more of a barrier to insight 
for persons with less complex ideas about themselves. Simply put, it may be more difficult to 
make sense of recalcitrant symptoms when persons have poorer capacity for self-reflection [54]. 
Conversely, individuals with greater capacities to think about their own thinking might be able to 
both recognize that it is unlikely that they truly possess special powers, as they previous thought, 
and may be able to further reflect that this belief becomes stronger when they are socially 
isolated or feeling rejected by others.   
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4.  Neurocognition and Anomalous Brain Structure and Function 
A second potential barrier to persons engaging in the kinds of reflective activity needed 
for the development of insight are neurocognitive deficits and anomalous brain functioning. For 
instance, it is possible that deficits in attention, memory, and executive functioning affect insight 
when they limit individuals’ access to memories of the various events associated with their 
mental illness. These deficits could further serve as a barrier to awareness of illness when they 
make it difficult to sort through what memories are available and either place those memories in 
sequence or determine what are the most salient aspects of those memories. While symptoms 
might present experiences that are difficult to make sense of, neurocognitive deficits might limit 
the person’s access to and ability to sort through the pieces of information which can be later 
assembled into a coherent account of psychiatric challenges [55, 56].  
In support of this, a meta-analysis of 35 studies suggested a significant but weak 
relationships between impaired insight and overall neurocognition with a mean weighted 
correlation coefficient of r = .17 with a 95% confidence interval ranging from .13 to .21 [57]. In 
another review of 34 studies Shad et al [58] reported that deficits in executive function measured 
with the Wisconsin Card Sorting Task were the aspect of neurocognitive functioning most 
frequently linked to insight. Others have found that both executive function and verbal memory 
are closely linked with insight in schizophrenia [59, 60, 44]. A recent first-episode study found 
that verbal memory and global cognitive functioning were predictive of impaired insight [61]. A 
separate study suggested that poor awareness of symptoms and consequences of illness were 
linked to reduced flexibility to manipulate incoming information [62]. Another study showed 
that deficits in episodic memory for negative autobiographical events likely play a role in 
impaired insight in schizophrenia [63]. As in the case of symptoms, a complicating factor is that 
poor neurocognition could also contribute to treatment non-adherence, creating another feedback 
loop through which symptoms and insight could be related. Indeed, a recent study found that 
better executive functioning and better insight were associated with increased medication 
adherence [64]. 
Of note, some studies have failed to find a link between neurocognition and insight.  
Zhou and colleagues [65], for example, examined the relationship between symptoms, insight, 
and cognition in 74 individuals with prolonged schizophrenia and insight was linked to clinical 
symptoms but not neuropsychological functioning. While neurocognition seems a promising 
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factor underlying the development and maintenance of insight in schizophrenia, further research 
is needed to delineate its exact role.  
In terms of brain structure and functioning, imaging studies suggest that areas which 
subserve impaired insight are also those associated with deficits in neurocognition [66, 67]. 
Several studies have indeed suggested that a lack of insight in schizophrenia spectrum disorders 
is related to aberrant structure and function of the frontocortical systems (see [68] for detailed 
review). Abnormalities related to insight in schizophrenia include reduced total brain volume, 
ventricular enlargement, frontal lobe atrophy, reduced frontal volume, and gray matter deficits in 
the cingulate, precuneus, temporal, and parietal lobes [68]. More recent investigations suggest 
that the complexity of insight as a construct may be reflected in neurobiology, as studies suggest 
that unawareness of illness and misattribution of symptoms may have independent biological 
bases in schizophrenia [58], with others reporting alterations in functional connectivity related to 
self-reflectivity and ultimately insight [69]. Recent studies have compared high and low insight 
groups amongst individuals with schizophrenia and found particular abnormalities and 
functioning in low insight groups [70, 71]. Nonetheless, even with the positive findings cited 
above, caution must be exercised as there have been other studies that call into question such 
associations due to negative findings [72, 73].   
 
5.  Deficits in Social Cognition and Poor Metacognition 
A third and fourth set of potential barriers to the development of insight involve 
processes which are central to reflectivity; specifically persons’ abilities to form ideas about 
themselves and others. The first of these is social cognition [74-76]. Social cognition refers to the 
affective, automatic, and willful processes, which allow people to grasp other’s mental states and 
the meanings of social interactions. Social cognition includes a number of components such as 
Theory of Mind (ToM), Affect Recognition, and Attributional Style [53]. The second process 
which may be related to insight is metacognition [77-80]. Metacognition refers to activities 
which allow persons to be aware of and form integrated and complex ideas about the self and 
others. Originally used in the education literature to describe an individual’s awareness of 
learning style [81], the term metacognition has since been expanded to an entire spectrum of 
mental activities. Metacognitive acts range from discrete processes, such as thinking about a 
thought, to more synthetic acts that require thoughts, feelings, and intentions to be integrated into 
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complex representations that later enable individuals to recognize and respond to life challenges 
[82-86]. While both these constructs are concerned with how persons are aware of each other, 
one operational difference between the two is that more synthetic forms of metacognition are 
assessed by analyzing discourse and not by assessing the correctness of a judgment. 
Theoretically, the assessment of metacognition seeks to capture a kind of understanding which is 
greater than the sum of its parts. Comparatively, ToM and Affect Recognition call for the correct 
detection of a discrete thought or feeling of another, while metacognition is interested in the 
integration of those details into a whole whose coherence is considered, rather than the absolute 
correctness of a judgment. Metacognition also includes the complex ability to shift back and 
forth from one’s own perspective to the valid and possibly differing perspectives of others [87-
90].  
Both social cognition and metacognition appear likely to be related to insight for several 
reasons. The development of insight requires, for instance, more than the acceptance of fact. 
Insight involves making a personally meaningful sense of how mental illness has and has not 
interrupted a unique life. Insight, for example, requires the development of: i) a sense of changes 
in one’s own and other’s internal states that have occurred as a result of the onset of mental 
illness; ii) the selection of pertinent historical events related to the illness; and iii) and judgments 
about the causal links between historical events. Only on the basis of this, can the emergence of 
mental illness be understood and an adaptive response formulated and enacted. We suggest that 
it is here where deficits in social cognition and metacognition could prove to be profound 
barriers to insight. With deficits in social cognition and metacognition persons might be 
manifestly unable to grasp to the perspectives of others and hence have a limited or myopic view 
of what has happened since the onset of mental illness. They might thus, for instance, reject the 
possibility that they are ill because the knowledge that is plain in the mind of others, for 
example, changes others have observed in their mental states, is inaccessible to them. Social 
cognitive and metacognitive deficits might, therefore, directly block the ability to perceive and 
trust the view of others that treatment is needed. Beyond this, deficits in social cognition and 
metacognition might further limit persons’ abilities to know how their own mental states have 
changed or are changing and to judge the impact of those changes on others. Thus, they might 
not know they are ill because they cannot see how profoundly different their own mental states 
are at present compared with experiences prior to the onset of mental illness. Indeed, without any 
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awareness of fluctuations in mental states, treatment might seem flatly unnecessary. Finally, 
deficits in metacognition and social cognition would likely have synergistically negative effects 
on insight. While deficits in social cognition might lead to incorrect assumptions about others, 
deficits in metacognition might lead to a lack of complex ideas about painful and confusing 
events. When these deficits are combined, it likely leads to a fragmented view, at best, of a life 
including experiences of mental illness. 
To date, evidence supporting the link of insight with social cognition and metacognition 
have been found in several sources. For one, broad deficits in both social cognition and 
metacognition have been found in patients with schizophrenia and exist independent of global 
levels of psychopathology and neurocognition [87, 88]. Regarding insight, one study matched 58 
individuals with prolonged schizophrenia with 56 matched controls on measures of Theory of 
Mind (ToM), neurocognition, and symptoms [74]. ToM impairments were shown to be 
significantly related to insight, independent of deficits in neurocognition or differing levels of 
symptom severity [74]. In another study, performance on tests of picture sequencing and joke 
appreciation were related to insight in 30 individuals with schizophrenia [91]. Quee and 
colleagues [53] showed that social cognition and neurocognition independently predicted insight 
in prolonged, but not first episode samples. The ability to recognize and appreciate the affective 
states of others [92], and perhaps even empathize with them [93], has also been linked to insight.  
Regarding metacognition, it has been shown that individuals with prolonged 
schizophrenia that have poor metacognition also tend to have poorer insight, even when 
controlling for deficits in neurocognition [54]. In studies that controlled for neurocognition, an 
independent sample of individuals with schizophrenia demonstrated again that those with good 
insight also had higher levels of metacognition and social cognition [76, 94]. A similar pattern 
has been observed in individuals early in the course of schizophrenia, as their ability to recognize 
and respond to psychological and social challenges was shown to be predictive of clinical insight 
[30]. These findings are consistent with imaging studies that suggest insight is related to 
structure and function in brain areas or circuits thought to support processes necessary for 
metacognition, including self-consciousness, self-other distinction, and self-referential 
procession [95-99].  
 
6.  Paradoxical Distress and the Contribution of Stigma 
D
ow
nl
oa
de
d 
by
 [D
r. 
Pa
ul 
Ly
sa
ke
r] 
at 
15
:02
 14
 Ju
ne
 20
16
 
Thus far, we have reviewed literature suggesting constructing a coherent account of 
psychiatric challenges can be complicated by symptoms and other deficits in schizophrenia 
spectrum disorders which may compromise the core processes which enable reflectivity 
including neurocognition, basic brain function, social cognition and metacognition.  However, it 
is vital to consider findings that awareness of mental illness is not awareness of an emotionally 
neutral set of events. In fact, multiple studies have suggested that acceptance of mental illness is 
profoundly distressing and as such the distress that may ensue with awareness could be another 
complicating factor for the development of insight.  
Improved insight has been linked to emotional distress and suicidality in both early and 
prolonged phases of the illness [20, 100, 101]. Paradoxically, with greater insight persons have 
been found to have higher levels of depression [102, 103, 48], lowered self-esteem [104], and 
decreased quality of life [105-107]. Exploration of these relationships has suggested that a range 
of factors influence whether insight causes distress including whether interventions are present 
[108] and a history of childhood trauma [109]. The view with the most research support is that 
the development of insight leads to distress when persons hold negative or stigmatizing beliefs 
about mental illness such as that having mental illness means that they are incompetent or 
dangerous [102]. In other words, insight may lead to emotional discomfort when it threatens an 
individual’s previous sense of identity, his or her understanding of the world, or when it leads to 
awareness of concrete losses (in function or relationships) that were previously not apparent 
[110]. In support of this are findings that when individuals have higher levels of internalized 
stigma, improved insight has been linked to depression, lesser meaning in life, and 
demoralization [111-115]. In one recent example, Cavelti and colleagues [116] found that higher 
levels of insight at baseline were associated with an increase in self-stigma over a 12-month 
study period, leading to increased demoralization, and, ultimately, poorer functioning.  
Additional support can be found in studies finding that patients who endorse stereotypes 
of mental illness are less likely to believe they have a mental illness [117]. Moreover, another 
study recently showed increased levels of poor insight are more common in cultures that are 
thought to have more stigmatizing beliefs about mental illness [118]. Concerning the influence of 
parental/caregiver insight on patient insight, patients with parents/caregivers who had less 
rejecting attitudes tended to have better insight [119]. Finally, structural equation modeling with 
284 people with schizophrenia spectrum disorders supported the hypothesis that insight 
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diminishes hope and increases depression and self-stigma [120]. In this study, negative 
symptoms reduced hope and increased depression and self-stigma, while positive symptoms 
diminished self-stigma through a pathway via insight. 
 
7. Emerging Interventions for Impaired Insight in Schizophrenia 
To date, the majority of approaches that have attempted to address impaired insight 
involve the use of treatment models or strategies originally designed to address other aspects of 
schizophrenia. Such approaches include treatment modalities such as cognitive behavioral 
therapy, motivational interviewing, psychosocial education, and social skills training. In a meta-
analytic review of the literature spanning from 1999 to 2012 Pijnenborg and colleagues [92], 
found that receiving treatment beyond usual care had a positive impact on insight, with 
psychoeducation and cognitive behavior therapy exerting marginal effects upon insight [92].  
More recently, however, as the factors that lead to or sustain poor insight have been 
elucidated, treatments have been developed with multiple components, each targeting a potential 
cause of poor insight. An example of this is a study by Lalova et al [121] which found that three 
forms of cognitive remediation aimed at improving neurocognition, autobiographical memory, 
and metacognition led to improved awareness of symptoms, as well as overall insight. A second 
example of a multicomponent treatment was designed by Guo et al [122] and includes cognitive 
behavior therapy, family therapy, psychoeducation, and skills training [122]. In a clinical trial 
testing the effects of this intervention, it was shown that this combination of practices resulted in 
improvements in insight and treatment attitudes above and beyond a treatment as usual group. A 
third example of a promising integrated treatment approach currently under rigorous 
investigation is REFLEX [92]. REFLEX involves three modules, each consisting of four one-
hour group sessions and dealing with factors that may promote insight. The modules target: 1) 
stigma; 2) developing a personal narrative; and 3) metacognition in the moment.  
Consistent with work on the role of metacognition in general reflectivity and insight, 
there has also been increasing interest in metacognitive-oriented psychotherapies to promote 
insight [123-129]. Although there are similarities with REFLEX in that many of the same issues 
are addressed, metacognitive-oriented therapies more directly target metacognitive deficits. One 
promising program that targets discrete forms of metacognition and promotes insight has been 
developed and offered by Moritz [130]. This program, Metacognitive Training for Schizophrenia 
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Patients (MCT), was originally designed as an eight module group intervention, but has also 
been implemented individually. MCT aims to increase awareness of cognitive biases via 
targeting biases such as jumping to conclusions, attributional style, metamemory, biases against 
dis-confirmatory evidence, and deficits in theory of mind. MCT promotes metacognitive skills 
and therefore is thought to facilitate symptom reduction and reduce the probability of relapse 
[131-133]. In a recent preliminary report, evidence was presented for another targeted program 
of metacognitive training for individuals with schizophrenia [123].  This intervention involves an 
individual, single-module intervention that specifically targets cognitive biases thought to 
contribute to delusions and impaired insight. The investigators found that the intervention had a 
positive overall impact on delusions, but also significantly improved clinical insight. 
Metacognitive training has also been tested and shown to be effective for promoting awareness 
of symptoms in a French sample [134]. Another study recently showed the targeting 
metacognition could decrease cognitive biases and improve clinical insight [124]. To date, 
however, metacognitive training has yet been linked specifically to improved cognitive insight. 
Another emerging metacognitively-oriented approach involves promoting insight across 
individual psychotherapy sessions. Metacognitive Reflection and Insight Therapy (MERIT) 
[135] is a manual-based model of psychotherapy designed for promoting the process of recovery 
in individuals with severe forms of mental illness. Of note, MERIT does not explicitly seek to 
improve insight.  It instead seeks to enhance the reflective capacity necessary for persons to form 
the kinds of integrated narratives which could form the structure of insight. At its core, MERIT 
seeks to promote metacognitive capacity through joint reflection upon the patient’s thoughts, 
hopes, wishes, memories and affective experiences. Interventions to stimulate metacognitive 
activity in MERIT are based on ongoing assessments of the patient’s current level of 
metacognitive functioning. MERIT conceptualizes metacognitive capacities as hierarchical, such 
that before persons are able to perform more complex levels of metacognitive function they must 
be capable of engaging in less complex levels. Patients with lesser capacities thus naturally need 
interventions to assist them to master basic capacities before attempting more complex ones.  As 
persons progress, however, it is expected that pain will emerge and metacognitive capacity may 
periodically be reduced and lower level metacognitive interventions may be necessary. In order 
to stimulate metacognition using MERIT, eight interrelated processes should occur within every 
session. These include positioning the patient’s agenda as primary, sharing of the therapist’s 
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thoughts without disrupting dialogue, eliciting a narrative episode(s), defining a psychological 
problem, discussing interpersonal processes in session, evaluating progress, stimulating 
reflective activities about the self and others, and finally, stimulating thoughts about how best to 
understand and to respond to psychological and social challenges [129]. Thus far, the evidence of 
feasibility of such approaches includes multiple case reports [125-129; 136-140] and a formal 
trial is currently underway [135].  
 
8. Summary and Conclusions 
Poor insight is not only a barrier to treatment engagement, but also a significant 
contributor to poor outcomes in individuals with schizophrenia spectrum disorders. However, 
insight has also been linked to emotional distress and increased stigma. Therefore, this review 
has offered an update from the literature regarding factors that significantly contribute to, and 
result from, impaired insight in schizophrenia. Specifically, an integrative model of poor insight 
has been proposed which stresses the role of impaired reflectivity in the development and 
maintenance of impaired insight with consideration of contributing factors such as symptoms, 
neurocognition deficits, social cognitive and metacognitive deficits, and social factors such as 
self-stigma. This model enables us to see how integrative therapeutic approaches that target 
reflectivity are needed which can address these factors as they are personally relevant for unique 
individuals in the spirit of the recovery movement. Further work is needed to assess the efficacy 
and implementation of novel, recovery-oriented approaches that emphasize increasing capacity 
for reflectivity and the impact these approaches may have on several outcomes, including 
insight.   
 
 
9. Expert Commentary 
The development of richer theoretical models of poor insight in schizophrenia have 
stressed that poor insight involves a relative failure to form a coherent and adaptive account of 
psychiatric challenges. This has led researchers to move beyond looking for the single cause of 
poor insight and instead to consider a range of biological, psychological and social factors whose 
interaction could hamper reflectivity and cause poor insight. As illustrated in Figure one, this 
work has suggested an integrative model of insight in which persons may be unaware that they 
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are ill as a result of: i) anomalous experiences (e.g. symptoms) which are difficult to make sense 
of, ii) neurocognitive deficits and related abnormalities in brain function which may impact 
persons abilities to access the kinds of information of which insight is composed, iii)  
metacognitive and iv) social cognitive deficits which may interfere with the integration of the 
information and v) stigma which may render the integration of that information inordinately 
painful and destructive.   
Taken as a whole, this work first suggests a number of potential paths to insight and 
indeed informs us that insight, like all forms of human meaning making, involves inordinately 
complex processes which can be bolstered or hindered by different factors. As an illustration, 
consider a person with schizophrenia who denies he is ill and possesses a crystallized belief that 
others are out to harm him. The integrative model tells us that his lack of insight could be the 
result of many things. The statement: “I am not ill… people really do want to harm me” could be 
a reflection of an inability to find another explanation for a powerful sense of not being safe. It 
could additionally be a reflection of an inability to remember actual recent events or decide 
which ones are salient. It could be a result of an inability to perceive or think in a nuanced way 
about other people, or to reflect upon the connections between one’s own thoughts and emotions. 
It might also be a way to avoid adopting a label which others erroneously equate with 
incompetence. Indeed, with so many factors at play the number of moderating and mediating 
relationships quickly grows and the number of potential factors may assist with explaining the 
host of contradictory findings by research which has historically considered only one set of 
factors at a time.   
One potentially limiting feature of many earlier models of insight in schizophrenia is that 
they conceptualized individuals with poor insight as merely passive observers of their life and 
the challenges that emerged within it. These views positioned patients as beings who should be 
taught that they are ill. As further illustrated in Figure 1, the integrative model of insight 
highlights how insight is not something that persons passively receive or develop in isolation. 
The development of insight involves the active creation of personalized meaning, which is in line 
with the dimensions of recovery recently emphasized as essential in mental health treatment 
[141]. At its core, this model of insight calls upon a range of reflective processes which are 
necessarily intrapersonal as well as interpersonal and take into account not merely the presence 
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of symptoms, but the meaning-making necessary to understand oneself as a complex being in an 
interpersonal world.   
This has far-reaching implications for the content of interventions and points to targets 
which take us well beyond the sphere of education. First, if we understand poor insight as a 
narrative phenomenon and acknowledge the importance of reflective processes, it is 
understandable that no single treatment modality thus far has demonstrated adequate 
effectiveness for improving insight in schizophrenia. Second, there are likely a range of 
formalized procedures needed to target the potential factors which sustain poor insight. 
Interventions could, for example, assist persons to decide how to think about anomalous 
experiences, or to recollect and sort through life events and decide which are the most salient. As 
is apparent in a number of new interventions, the most effective treatment might seek to help 
persons to piece life events together into coherent accounts of one’s life, in a way that ultimately 
rejects stigma. Certainly, the evidence from emerging protocols cited above indicates that those 
procedures are acceptable to patients and can be delivered in an effective way.  
Even beyond issues of content, however, the integrative model has even deeper 
implications for the processes involved in treatment. Specifically, the model points to the need to 
work with persons to think about issues rather than encourage them to believe certain things. In 
such interventions, patients would not be instructed to accept certain facts but instead engaged in 
the kind of dialogue that promotes meaning making. Although the treatments adhering to these 
principals are in the relatively early stages of testing, these novel interventions are also consistent 
with the principles of recovery, stressing that recovery is not just symptom remission or the 
attainment of psychosocial milestones, but requires feeling empowered as an active agent in 
one’s own life.  
 
10. Five Year View 
There is a growing body of evidence to support the clinical utility of clarifying the 
influence of factors that contribute to insight. However, even with decades of research into such 
factors, a comprehensive understanding of poor insight in schizophrenia spectrum disorders 
remains elusive. Over the next five years, the field awaits development and testing of more 
inclusive models. Future research regarding insight will benefit from contemporary models that 
integrate the importance of reflective processes, such as awareness of changes in one’s own and 
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other’s internal states, recognition of pertinent historical events related to the illness, and 
judgment about the causal links between historical events and the synthesis of that information 
into a coherent representation and plan of action for dealing with such challenges [2, 80, 53, 
137]. More specifically, there is a need for further investigation into how insight is influenced by 
self and other reflectivity in the contexts of social cognition and metacognition.  
Research to date has also identified a number of other potential directions that should be 
further explored in order to promote understanding of impaired insight in schizophrenia spectrum 
disorders. First, larger and more inclusive cross-sectional studies are needed that examine 
influencing variables and explore directionality of established relationships. For instance, future 
studies should include domains such as psychopathology, cognition, metacognition and social 
cognition, stigma, trauma, self-esteem, hope, and personality. Second, longitudinal studies of 
insight over the course of schizophrenia and across the lifespan are needed. Such studies could 
elucidate how insight is influenced over time by associated variables. These types of studies 
could also address a number of important research questions about the stability of insight and its 
potential improvements, the nature of the associations among related factors as insight improves, 
and specifically how ongoing development of personal narratives impact insight. A third area of 
potential research on insight is furthering understanding of the multiple domains of illness 
awareness. While some studies have already begun to explore these questions [54], future studies 
should continue to involve additional goals such as clarifying potential shared and unique 
influences of variables such as symptoms, neurocognition, and metacognition upon the unique 
domains of clinical insight: awareness of illness, illness consequences, and need for treatment. 
This work would also need to be examined longitudinally to incorporate fuller understanding of 
variable influence and links to insight domains over time. A fourth area of potential research 
includes future investigations that serve to elucidate how brain structure and function impact 
insight, as investigations into this could be informative for developing both advances into 
etiological theory and novel therapeutic approaches. To date, imaging studies suggest that a 
number of areas and anomalies may subserve impaired insight, including reduced total brain 
volume, ventricular enlargement, frontal lobe atrophy, reduced frontal volume, gray matter 
deficits in the cingulate, precuneus, temporal and parietal lobes [68]. However, continued 
research is needed for replication as well as to clarify how these abnormalities fit together and 
manifest clinically as impaired insight. A fifth area of potential research involves the need for 
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continued innovation in treatment approaches. Unlike most currently available interventions, 
future development and investigation of emerging therapies should focus on incorporating 
reflective and narrative processes into therapy. Thus far, the evidence of feasibility of such 
approaches includes a number of case reports [138, 125-129] and a formal trial currently 
underway [135]. However, additional randomized control trials, over adequate periods of time 
(at least 6 months) and with larger and more diverse samples are needed. These studies should 
also incorporate ongoing assessment of a number of factors related to insight, including but not 
limited to psychopathology, neurocognition, metacognition, social cognition, and social factors. 
This data would enable clarification of how each of these domains may potentially impact illness 
awareness.  
In sum, it is becoming increasingly necessary to better define the phenomenology of poor 
insight and integrate neurobiological and psychological findings as well as the social context as 
discussed in the present review. It seems that it will be particularly important to tease apart the 
influence of positive, negative, and perhaps others types of symptoms, upon insight. Moreover, 
there seems to be mounting evidence that looking at particular neurocognitive domains or 
specific combinations of such domains may be imperative to elucidating their influence upon 
insight. More clarification regarding the neuroanatomical and functional bases of insight is also 
needed. Specific areas that have been identified as relevant, such as frontocortical areas and the 
anterior cingulate, should be further explored. While we have pointed to the need for the study of 
specific areas, future meta-analyses are also needed. Finally, future research is needed to inform 
and test novel, more effective interventions for improving insight, and ultimately outcomes, in 
individuals living with schizophrenia.  
 
 
 
 
11. Key Issues 
• Impaired insight, or unawareness of illness, is a commonly observed feature of 
schizophrenia spectrum disorders. 
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• Impaired insight is a barrier to treatment and significantly contributes to poorer outcomes 
for individuals with schizophrenia. However, how this complex, multi-dimensional 
construct is developed and sustained remains incompletely understood. 
• Contemporary models of insight suggest that a limited capacity for reflectivity, or a 
failure to construct an adaptive understanding of a complex series of events which result 
from mental illness, may be a direct or moderating antecedent of poor insight.  
• Research suggested an integrative model of poor insight in which poor insight may 
develop in the face of the face of symptoms, neurocognition deficits, social cognitive and 
metacognitive deficits, and social factors such as self-stigma.   
• A number of emerging, integrated approaches are being developed to better address the 
antecedents of poor insight in schizophrenia as illustrated by the integrated model of poor 
insight. 
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Figure 1. An integrative model of poor insight in schizophrenia spectrum disorders. Each box represents 
a construct. Solid black arrows illustrate the relationships among constructs. Broken arrows 
represent potential mediating and moderating relationships. 
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